Please try another search
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies in the United States and internationally. Its lead product candidate is CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma. The company also develops CB-011, an allogeneic anti-BCMA CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory multiple myeloma; and CB-012, an allogeneic anti-CD371 CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory acute myeloid leukemia. Caribou Biosciences, Inc. was incorporated in 2011 and is headquartered in Berkeley, California.
Name | Age | Since | Title |
---|---|---|---|
Rachel E. Haurwitz | 36 | 2011 | Co-Founder, CEO, President & Director |
Martin Jinek | - | - | Member of Scientific Advisory Board |
Andrew L. Guggenhime | 54 | 2021 | Independent Chairman |
Katy Rezvani | - | - | Member of Scientific Advisory Board |
Scott N. Braunstein | 59 | 2021 | Independent Director |
Jennifer A. Doudna | 58 | - | Member of Scientific Advisory Board |
Cameron J. Turtle | - | - | Member of Scientific Advisory Board |
Natalie R. Sacks | 57 | 2018 | Independent Director |
Noopur Raje | - | - | Member of Scientific Advisory Board |
Dara Richardson-Heron | 59 | 2021 | Independent Director |
Ami Bhatt | - | - | Member of Scientific Advisory Board |
Ran Zheng | 59 | 2021 | Independent Director |
Nancy Whiting | 50 | 2021 | Independent Director |
David Lee Johnson | 54 | 2022 | Independent Director |
Stephen J. Schuster | - | 2023 | Member of Scientific Advisory Board |
Sundar Jagannath | - | 2023 | Member of Scientific Advisory Board |
Akos Czibere | - | 2024 | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review